Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Health Systems, Economic Evaluations, Quality of Life, and Cholinesterase and Neurodegenerative Diseases.
Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90
Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
A statistical framework for cross-tissue transcriptome-wide association analysis.
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
A randomized clinical trial to evaluate home-based assessment of people over 75 years old.
Version 3 of the Alzheimer Disease Centers’ Neuropsychological Test Battery in the Uniform Data Set (UDS)
Transethnic genome‐wide scan identifies novel Alzheimer's disease loci
Assessment of the genetic variance of late-onset Alzheimer's disease
<i>ABCA7</i> frameshift deletion associated with Alzheimer disease in African Americans
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Targeting Prodromal Alzheimer Disease With Avagacestat
Tracking Early Decline in Cognitive Function in Older Individuals at Risk for Alzheimer Disease Dementia
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease
The Alzheimer's Disease Cooperative Study Prevention Instrument Project: Longitudinal Outcome of Behavioral Measures as Predictors of Cognitive Decline
Rarity of the Alzheimer Disease–Protective<i>APP</i>A673T Variant in the United States
Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review
Language impairment in Alzheimer&#39;s disease and benefits of acetylcholinesterase inhibitors
Novel White Matter Tract Integrity Metrics Sensitive to Alzheimer Disease Progression
White matter tract integrity metrics reflect the vulnerability of late-myelinating tracts in Alzheimer's disease
Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer’s disease
Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly.